PLOS ONE: Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
![PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/b848b4c36977bfee20ba4b3ed5bd220554206359/3-Figure1-1.png "PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar")
PDF] Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study | Semantic Scholar
2021 Focused update of the 2017 consensus guidelines of the Asia Pacific Heart Rhythm Society (APHRS) on stroke prevention in atrial fibrillation - Chao - 2021 - Journal of Arrhythmia - Wiley Online Library
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
PLOS ONE: Adherence to rivaroxaban versus apixaban among patients with non-valvular atrial fibrillation: Analysis of overall population and subgroups of prior oral anticoagulant users
Comparison of Adherence to Rivaroxaban Versus Apixaban Among Patients With Atrial Fibrillation - ScienceDirect
RIVER Trial Presented at #AHA20 / Twitter
Recommendations on antithrombotic treatment during the COVID-19 pandemic. Position statement of the Working Group on Cardiovascular Thrombosis of the Spanish Society of Cardiology | Revista Española de Cardiología
Warfarin in patients with mechanical heart valves | The BMJ
A randomized clinical trial to evaluate the efficacy and safety of rivaroxaban in patients with bioprosthetic mitral valve and atrial fibrillation or flutter: Rationale and design of the RIVER trial - ScienceDirect
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
Rivaroxaban Versus Warfarin in Patients with Mechanical Heart Valves: Open-Label, Proof-of-Concept trial—The RIWA study | SpringerLink
หนอนน้อยอ่านเปเปอร์ - Contraindications to the Use of Non–Vitamin K Oral Anticoagulants (ตามรูป) o Valvular atrial fibrillation (prosthetic valve, rheumatic mitral valvular disease, prior mitral valve repair) o Mechanical prosthetic heart valve o
Rivaroxaban versus Warfarin in Patients with Mechanical Heart Valve: Rationale and Design of the RIWA Study. - Abstract - Europe PMC
Anticoagulation for Mechanical Heart Valves | Arteriosclerosis, Thrombosis, and Vascular Biology
Rivaroxaban and Dabigatran for Suppression of Mechanical Heart Valve–Induced Thrombin Generation - The Annals of Thoracic Surgery
RIVERtrial - Twitter Search / Twitter
PDF) RIVAROXABAN VERSUS WARFARIN IN PATIENTS WITH MECHANICAL HEART VALVE: PRELIMINARY RESULTS
PDF) Mechanical Valve Thrombosis on Rivaroxaban: Are Novel Anticoagulants Really an Option?
Rivaroxaban in Patients with Atrial Fibrillation and a Bioprosthetic Mitral Valve | NEJM
Rivaroxaban noninferior to warfarin in patients with AF, bioprosthetic mitral valve: RIVER
Apixaban Versus Warfarin for Mechanical Heart Valve Thromboprophylaxis in a Swine Aortic Heterotopic Valve Model | Arteriosclerosis, Thrombosis, and Vascular Biology
Antithrombotic Therapy in Patients With Valvular Heart Disease
Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Warfarin After Bioprosthetic Valve Replacements | Semantic Scholar
VisualAbstract: Rivaroxaban noninferior to warfarin in patients with atrial fibrillation and bioprosthetic mitral valves | 2 Minute Medicine
